MRNA vs AMGN: Which Stock is Better?
Side-by-side comparison of Moderna Inc and Amgen Inc in 2026
MRNA
Moderna Inc
$53.57
AMGN
Amgen Inc
$388.16
Key Metrics Comparison
| Metric | MRNA | AMGN | Winner |
|---|---|---|---|
| Market Cap | $20.93B | $209.24B | AMGN |
| P/E Ratio | N/A | 27.24 | AMGN |
| EPS (TTM) | $N/A | $14.25 | AMGN |
| Revenue Growth | -0.3% | 0.1% | AMGN |
| Gross Margin | -105.8% | 70.8% | AMGN |
Analyze MRNA
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is MRNA or AMGN a better investment?
Comparing MRNA and AMGN: Moderna Inc has a market cap of $20.93B while Amgen Inc has $209.24B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between MRNA and AMGN?
MRNA (Moderna Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: MRNA or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: MRNA or AMGN?
AMGN has higher revenue growth at 0.1% vs -0.3% for MRNA.
Which company is more profitable: MRNA or AMGN?
Amgen Inc (AMGN) has higher gross margins at 70.8% compared to -105.8% for MRNA.
Which is the larger company: MRNA or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $209.24B compared to $20.93B for MRNA.
Should I buy MRNA or AMGN in 2026?
Both MRNA and AMGN have investment merit. MRNA trades at $53.57 while AMGN trades at $388.16. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between MRNA and AMGN stock?
Key differences: Market Cap ($20.93B vs $209.24B), P/E Ratio (N/A vs 27.2x), Revenue Growth (-0.3% vs 0.1%), Gross Margin (-105.8% vs 70.8%).